Further studies using the GEPIA database revealed that the expression levels of SLC22A6, SLC22A7, SLC22A13, SLC25A4, SLC34A1, and SLC44A4 in ccRCC correlated with the clinical stage of the cancer, as shown in Figure 3(b). This evidence concerns the gene SLC25A4 and cancer.